Cencora (COR): are the analysts right?

Cencora · Health Care · ref. ETF XLV · 50 calls · price $304.48
What the company does: Cencora source et distribue des produits pharmaceutiques aux États-Unis et à l'international.
📈 1-year price
$304.48+2.2% over range
Jul 8, 25low $252.74 · high $374.75Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
82% recommend buying · 11 analysts

🎯 Analyst price target on COR

High target · 1 analyst$440+44.5%
Median target · 10 analysts$352.5+15.8%
Low target · 1 analyst$285-6.4%
Current price$304.48

🗳️ The analyst consensus

Analyst breakdown · 11 (6 months)
Strong Buy0%
Buy82%
Hold18%
Sell0%
Strong Sell0%

💰 Cencora dividend

0.81%annual yield
That's ~$2.35 per share per year.

✅ Historical analyst reliability on COR

Most reliable analysts on COR (% profitable · 365j · ≥2 calls)
Evercore ISI Group 100% +46.1% 2
JP Morgan 100% +30.6% 2
UBS 100% +26.0% 2
Baird 80% +24.3% 5
Citigroup 50% +9.2% 2

📊 What $1,000 invested in Cencora would be worth

In short — $1,000 invested in Cencora 10 years ago would be worth $2,729 today, i.e. +11%/yr on average. Best year: 2025 (+50%), worst: 2016 (-25%). Price performance, excluding dividends.

If I'd invested $1,000 in Cencora

InvestmentWorth todayGain
1 years ago$1,259+26%
3 years ago$1,708+71%
5 years ago$2,895+189%
10 years ago$2,729+173%
since inception (1995)$99,508+9851%

Return by year (Cencora)

YearReturn$1,000 invested at year start
2026 (YTD)-16%$838 (-16%)
2025+50%$1,259 (+26%)
2024+9%$1,378 (+38%)
2023+24%$1,708 (+71%)
2022+25%$2,129 (+113%)
2021+36%$2,895 (+189%)
2020+15%$3,328 (+233%)
2019+14%$3,803 (+280%)
2018-19%$3,082 (+208%)
2017+17%$3,619 (+262%)
2016-25%$2,729 (+173%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance💰 Dividend
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on COR

■ Neutral neutral · not a buy · 🎯$285
Price at call : $286.95 — gap to target -1%
Today : $304.48 — gap to target -6%
🎯 on COR : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Jun 24, 27
Barclays
Jun 10, 26
▲ Overweight · 🎯$350
Price at call : $281.48 — upside +24%
Today : $304.48 — upside +15%
🎯 on COR : 100% (1 call matured) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Jun 10, 27
Wells Fargo
May 11, 26
▲ Overweight · 🎯$331
Price at call : $259.7 — upside +27%
Today : $304.48 — upside +9%
🎯 on COR : 0% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : May 11, 27
UBS
May 8, 26
▲ Buy · 🎯$412
Price at call : $261.08 — upside +58%
Today : $304.48 — upside +35%
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : May 8, 27
Citigroup
May 7, 26
▲ Buy · 🎯$355
Price at call : $261.08 — upside +36%
Today : $304.48 — upside +17%
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : May 7, 27
▲ Outperform · 🎯$300
Price at call : $261.08 — upside +15%
Today : $304.48 — upside -1%
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : May 7, 27
Baird
May 7, 26
▲ Outperform · 🎯$339
Price at call : $255.66 — upside +33%
Today : $304.48 — upside +11%
🎯 on COR : 80% (5 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : May 7, 27
William Blair
Apr 28, 26
■ Market Perform neutral · not a buy
🎯 on COR : no call matured yet · 📊 on Health : 65.4% · +5.6% (26 calls)
in progress (365j)
matures : Apr 28, 27
▲ Outperform · 🎯$360
Price at call : $322.46 — upside +12%
Today : $304.48 — upside +18%
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Apr 8, 27
Barclays
Feb 13, 26
▲ Overweight · 🎯$425
Price at call : $359.97 — upside +18%
Today : $304.48 — upside +40%
🎯 on COR : 100% (1 call matured) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 13, 27
JP Morgan
Feb 10, 26
▲ Overweight · 🎯$419
Price at call : $365.7 — upside +15%
Today : $304.48 — upside +38%
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Feb 10, 27
Wells Fargo
Feb 10, 26
▲ Overweight · 🎯$429
Price at call : $360 — upside +19%
Today : $304.48 — upside +41%
🎯 on COR : 0% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Feb 10, 27
▲ Outperform · 🎯$420
Price at call : $359.25 — upside +17%
Today : $304.48 — upside +38%
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Feb 5, 27
▲ Overweight · 🎯$400
Price at call : $359.22 — upside +11%
Today : $304.48 — upside +31%
🎯 on COR : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Jan 29, 27
Jefferies
Jan 22, 26
▲ Buy · 🎯$440
Price at call : $352.47 — upside +25%
Today : $304.48 — upside +45%
🎯 on COR : no call matured yet · 📊 on Health : 50.5% · +4.5% (376 calls)
in progress (365j)
matures : Jan 22, 27
■ Neutral neutral · not a buy · 🎯$360
Price at call : $340.92 — gap to target +6%
Today : $304.48 — gap to target +18%
🎯 on COR : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Jan 5, 27
Barclays
Dec 9, 25
▲ Overweight · 🎯$400
Price at call : $340.79 — upside +17%
Today : $304.48 — upside +31%
🎯 on COR : 100% (1 call matured) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Dec 9, 26
JP Morgan
Nov 11, 25
▲ Overweight · 🎯$417
Price at call : $363.42 — upside +15%
Today : $304.48 — upside +37%
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Nov 11, 26
Wells Fargo
Nov 11, 25
▲ Overweight · 🎯$405
Price at call : $365.08 — upside +11%
Today : $304.48 — upside +33%
🎯 on COR : 0% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Nov 11, 26
TD Cowen
Nov 10, 25
▲ Buy · 🎯$400
Price at call : $365.08 — upside +10%
Today : $304.48 — upside +31%
🎯 on COR : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Nov 10, 26
UBS
Nov 7, 25
▲ Buy · 🎯$415
Price at call : $364.65 — upside +14%
Today : $304.48 — upside +36%
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Nov 7, 26
Baird
Nov 6, 25
▲ Outperform · 🎯$395
Price at call : $360.7 — upside +10%
Today : $304.48 — upside +30%
🎯 on COR : 80% (5 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Nov 6, 26
Mizuho
Nov 6, 25
▲ Outperform · 🎯$380
Price at call : $360.24 — upside +5%
Today : $304.48 — upside +25%
🎯 on COR : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)
in progress (365j)
matures : Nov 6, 26
Mizuho
Oct 30, 25
▲ Outperform · 🎯$340
Price at call : $341.21 — upside -0%
Today : $304.48 — upside +12%
🎯 on COR : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)
in progress (365j)
matures : Oct 30, 26
UBS
Oct 27, 25
▲ Buy · 🎯$380
Price at call : $335.64 — upside +13%
Today : $304.48 — upside +25%
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Oct 27, 26
Mizuho
Oct 16, 25
▲ Outperform · 🎯$334
Price at call : $319.4 — upside +5%
Today : $304.48 — upside +10%
🎯 on COR : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)
in progress (365j)
matures : Oct 16, 26
Wells Fargo
Aug 13, 25
▲ Overweight · 🎯$354
Price at call : $291.04 — upside +22%
Today : $304.48 — upside +16%
🎯 on COR : 0% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Aug 13, 26
■ Equal-Weight neutral · not a buy · 🎯$330
Price at call : $297.83 — gap to target +11%
Today : $304.48 — gap to target +8%
🎯 on COR : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Jul 16, 26
Jefferies
Jun 30, 25
■ Hold neutral · not a buy · 🎯$300
Price at call : $295.33 — gap to target +2%
Today : $304.48 — gap to target -1%
🎯 on COR : no call matured yet · 📊 on Health : 50.5% · +4.5% (376 calls)
in progress (365j)
matures : Jun 30, 26
Wells Fargo
Jun 3, 25
▲ Overweight · 🎯$337
Price at call : $291.55 — upside +16%
Today : $304.48 — upside +11%
Expected +16% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on COR : 0% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
-9.6%
stock -10% · XLV +11%
Citigroup
May 8, 25
▲ Buy · 🎯$355
Price at call : $283 — upside +25%
Today : $304.48 — upside +17%
Expected +25% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
-8.2%
stock -8% · XLV +8%
Baird
May 8, 25
▲ Outperform · 🎯$350
Price at call : $283.77 — upside +23%
Today : $304.48 — upside +15%
Expected +23% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on COR : 80% (5 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
-8.0%
stock -8% · XLV +7%
UBS
Apr 29, 25
▲ Buy · 🎯$335
Price at call : $292.67 — upside +14%
Today : $304.48 — upside +10%
Expected +14% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
+5.2%
stock +5% · XLV +4%
■ Neutral neutral · not a buy · 🎯$285
Price at call : $284.33 — gap to target +0%
Today : $304.48 — gap to target -6%
🎯 on COR : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Apr 11, 26
Wells Fargo
Mar 14, 25
■ Equal-Weight neutral · not a buy · 🎯$274
Price at call : $260.96 — gap to target +5%
Today : $304.48 — gap to target -10%
🎯 on COR : 0% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Mar 14, 26
▲ Outperform · 🎯$280
Price at call : $247.88 — upside +13%
Today : $304.48 — upside -8%
Expected +13% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 47.6% · +1.3% (147 calls)
+46.6%
stock +47% · XLV +7%
Wells Fargo
Jan 29, 25
■ Equal-Weight neutral · not a buy · 🎯$251
Price at call : $255.94 — gap to target -2%
Today : $304.48 — gap to target -18%
🎯 on COR : 0% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Jan 29, 26
JP Morgan
Jan 24, 25
▲ Overweight · 🎯$301
Price at call : $254.89 — upside +18%
Today : $304.48 — upside -1%
Expected +18% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
+39.5%
stock +39% · XLV +7%
Wells Fargo
Dec 13, 24
■ Equal-Weight neutral · not a buy · 🎯$237
Price at call : $229.82 — gap to target +3%
Today : $304.48 — gap to target -22%
🎯 on COR : 0% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Dec 13, 25
Baird
Nov 7, 24
▲ Outperform · 🎯$292
Price at call : $248.41 — upside +18%
Today : $304.48 — upside -4%
Expected +18% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 80% (5 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
+46.8%
stock +47% · XLV -2%
UBS
Nov 7, 24
▲ Buy · 🎯$285
Price at call : $248.41 — upside +15%
Today : $304.48 — upside -6%
Expected +15% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
+46.8%
stock +47% · XLV -2%
Barclays
Nov 7, 24
▲ Overweight · 🎯$290
Price at call : $248.41 — upside +17%
Today : $304.48 — upside -5%
Expected +17% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 100% (1 call matured) · 📊 on Health : 50.1% · +2.2% (617 calls)
+46.8%
stock +47% · XLV -2%
▲ Outperform · 🎯$285
Price at call : $247.76 — upside +15%
Today : $304.48 — upside -6%
Expected +15% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 47.6% · +1.3% (147 calls)
+45.6%
stock +46% · XLV -2%
JP Morgan
Aug 21, 24
▲ Overweight · 🎯$287
Price at call : $240.59 — upside +19%
Today : $304.48 — upside -6%
Expected +19% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
+21.6%
stock +22% · XLV -11%
Wells Fargo
Aug 1, 24
■ Equal-Weight neutral · not a buy · 🎯$249
Price at call : $247.57 — gap to target +1%
Today : $304.48 — gap to target -18%
🎯 on COR : 0% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Aug 1, 25
Baird
Aug 1, 24
▲ Outperform · 🎯$287
Price at call : $244.46 — upside +17%
Today : $304.48 — upside -6%
Expected +17% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 80% (5 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
+17.9%
stock +18% · XLV -13%
Baird
Jul 9, 24
▲ Outperform · 🎯$285
Price at call : $222.37 — upside +28%
Today : $304.48 — upside -6%
Expected +28% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 80% (5 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
+35.0%
stock +35% · XLV -7%
▲ Outperform · 🎯$275
Price at call : $225.3 — upside +22%
Today : $304.48 — upside -10%
Expected +22% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 100% (1 call matured) · 📊 on Health : 57.1% · +6.2% (35 calls)
+33.1%
stock +33% · XLV -8%
Baird
May 2, 24
▲ Outperform · 🎯$277
Price at call : $224.74 — upside +23%
Today : $304.48 — upside -9%
Expected +23% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 80% (5 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
+30.0%
stock +30% · XLV -1%
Citigroup
Apr 30, 24
▲ Buy · 🎯$280
Price at call : $229.2 — upside +22%
Today : $304.48 — upside -8%
Expected +22% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
+26.7%
stock +27% · XLV -3%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)